Functional genomic screens and AI: a key partnership for successful therapeutic development.
CRISPR gene-editing and AI are crucial tools in the early stages of developing therapies for the treatment of human disease. Such screens generate myriad datapoints that humans are unable to sift through without computational input.
Please join us to learn how the Milner Therapeutics Institute uses both approaches and wide-reaching collaborations input into all stages of the translational pathway from Innovation through to patients and back.
Speakers:
Nicola McCarthy, Head of Research, Milner Therapeutics Institute, University of Cambridge
and
Namshik Han, Head of Computational Biology and AI, Milner Therapeutics Institute, University of Cambridge
This talk is free to attend for:
- Cambridge Network members
- Current staff and students of the University of Cambridge and of Anglia Ruskin University
- Milner affiliates, Frame Shift companies and Consortium members
Please email louise.rushworth@cambridgenetwork.co.uk to sign up if you don't have a Cambridge Network login.
More information and registration at: cambridgenetwork.co.uk/events/functional-genomic-screens-and-ai-key-partnership-successful-therapeutic-development
Read more about Milner Therapeutics Institute research at: milner.cam.ac.uk/cpa/
16:30pm-19:00pm (presentations 17:00-18:00)
